Filtros : "2021" "FCF004" "Emirados Árabes Unidos" Limpar

Filtros



Refine with date range


  • Source: Current Drug Targets. Unidade: FCF

    Subjects: DOENÇAS NEGLIGENCIADAS, ANTIMALÁRICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BONIFACE, Pone Kamdem e FERREIRA, Elizabeth Igne. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, v. 22, p. 379-398, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389450121666201228122239. Acesso em: 09 out. 2024.
    • APA

      Boniface, P. K., & Ferreira, E. I. (2021). The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, 22, 379-398. doi:10.2174/1389450121666201228122239
    • NLM

      Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2024 out. 09 ] Available from: https://doi.org/10.2174/1389450121666201228122239
    • Vancouver

      Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2024 out. 09 ] Available from: https://doi.org/10.2174/1389450121666201228122239
  • Source: Mini-Reviews in Medicinal Chemistry. Unidades: FCFRP, FCF

    Assunto: FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA, Elys Juliane Cardoso et al. Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, v. 21, n. 16, p. 2227-2248, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389557521666210226145328. Acesso em: 09 out. 2024.
    • APA

      Lima, E. J. C., Gomes, R. A., Fornari, E., Emery, F. da S., & Trossini, G. H. G. (2021). Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, 21( 16), 2227-2248. doi:10.2174/1389557521666210226145328
    • NLM

      Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 out. 09 ] Available from: https://doi.org/10.2174/1389557521666210226145328
    • Vancouver

      Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 out. 09 ] Available from: https://doi.org/10.2174/1389557521666210226145328
  • Source: Current Topics in Medicinal Chemistry. Unidade: FCF

    Subjects: TUBERCULOSE, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS, QUIMIOTERAPIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PRIMI, Marina Candido et al. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, v. 21, p. 1186-1197, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026621666210728094804. Acesso em: 09 out. 2024.
    • APA

      Primi, M. C., Tavares, M. T., Klein, L. L., Izard, T., Sant'Anna, C. M. R., Franzblau, S. G., & Ferreira, E. I. (2021). Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, 21, 1186-1197. doi:10.2174/1568026621666210728094804
    • NLM

      Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 out. 09 ] Available from: https://doi.org/10.2174/1568026621666210728094804
    • Vancouver

      Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 out. 09 ] Available from: https://doi.org/10.2174/1568026621666210728094804
  • Source: Current Organic Chemistry. Unidade: FCF

    Subjects: QUIMIOTERÁPICOS, COMPOSTOS HETEROCÍCLICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PRASHER, Parteek et al. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review. Current Organic Chemistry, v. 25, p. 654-668, 2021Tradução . . Disponível em: https://doi.org/10.2174/1385272824999200820152501. Acesso em: 09 out. 2024.
    • APA

      Prasher, P., Sharma, M., Zacconi, F., Gupt, G., Aljabali, A. A., Mishra, V., et al. (2021). Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review. Current Organic Chemistry, 25, 654-668. doi:10.2174/1385272824999200820152501
    • NLM

      Prasher P, Sharma M, Zacconi F, Gupt G, Aljabali AA, Mishra V, Tambuwala MM, Kapoor DN, Negi P, Pinto T de JA, Singh I, Chellappan DK, Dua K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review [Internet]. Current Organic Chemistry. 2021 ; 25 654-668.[citado 2024 out. 09 ] Available from: https://doi.org/10.2174/1385272824999200820152501
    • Vancouver

      Prasher P, Sharma M, Zacconi F, Gupt G, Aljabali AA, Mishra V, Tambuwala MM, Kapoor DN, Negi P, Pinto T de JA, Singh I, Chellappan DK, Dua K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review [Internet]. Current Organic Chemistry. 2021 ; 25 654-668.[citado 2024 out. 09 ] Available from: https://doi.org/10.2174/1385272824999200820152501
  • Source: Medicinal Chemistry. Unidade: FCF

    Subjects: AGENTES ANTIMICROBIANOS, ANTIOXIDANTES, RESISTÊNCIA MICROBIANA ÀS DROGAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERNANDES, Thais Batista et al. Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking. Medicinal Chemistry, v. 17, p. 474-484, 2021Tradução . . Disponível em: https://doi.org/10.2174/1573406415666191122111228. Acesso em: 09 out. 2024.
    • APA

      Fernandes, T. B., Segretti, N. D., Lourenço, F. R., Cândido, T. M., Baby, A. R., Barbosa, E. G., & Parise Filho, R. (2021). Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking. Medicinal Chemistry, 17, 474-484. doi:10.2174/1573406415666191122111228
    • NLM

      Fernandes TB, Segretti ND, Lourenço FR, Cândido TM, Baby AR, Barbosa EG, Parise Filho R. Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking [Internet]. Medicinal Chemistry. 2021 ; 17 474-484.[citado 2024 out. 09 ] Available from: https://doi.org/10.2174/1573406415666191122111228
    • Vancouver

      Fernandes TB, Segretti ND, Lourenço FR, Cândido TM, Baby AR, Barbosa EG, Parise Filho R. Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking [Internet]. Medicinal Chemistry. 2021 ; 17 474-484.[citado 2024 out. 09 ] Available from: https://doi.org/10.2174/1573406415666191122111228

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024